Modeling the Acute Mucosal Toxicity of Fractionated Radiotherapy Combined with the ATM Inhibitor WSD0628
2024 · Molecular Cancer Therapeutics · 3 citations
https://doi.org/10.1158/1535-7163.mct-24-0664
M
Margaret A. Connors
Mayo Clinic(US)
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
44
Papers
205
Citations
8
h-index
7
i10-index
Margaret A. Connors is an academic researcher from Mayo Clinic. The author has contributed to research in topics: Cancer therapeutics and mechanisms & Synthesis of Tetrazole Derivatives & Chemical Reactions and Isotopes. The author has an h-index of 8, co-authored 38 publications.
ORCID: 0000-0002-0094-0030Papers by this author
worksSupplementary Figure 1 from Differential Distribution of the DNA-PKcs Inhibitor Peposertib Selectively Radiosensitizes Patient-derived Melanoma Brain Metastasis Xenografts
2024 · 0 citations
https://doi.org/10.1158/1535-7163.25735661
Supplementary Figure 1 from Differential Distribution of the DNA-PKcs Inhibitor Peposertib Selectively Radiosensitizes Patient-derived Melanoma Brain Metastasis Xenografts
2024 · 0 citations
https://doi.org/10.1158/1535-7163.27102355.v1
Supplementary Figure 2 from Differential Distribution of the DNA-PKcs Inhibitor Peposertib Selectively Radiosensitizes Patient-derived Melanoma Brain Metastasis Xenografts
2024 · 0 citations
https://doi.org/10.1158/1535-7163.27102352.v1
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat